CLO equity stress test reveals the danger behind 22% yields

Oxford Square's headline ~22% yield is largely funded by capital return, not earnings: Q4 2025 distribution was $0.105/share vs NII of $0.07 (payout ratio ~150%), and NAV fell from $2.30 (YE2024) to $1.69 (Q4 2025). CLO equity effective yield compressed from 9.7% (Q3 2025) to 8.6% (Q4) and cash distribution yield fell from 16.0% (Q1) to 13.8% (Q2) after the Fed cut 75bps; the distress ratio on underlying loans rose to 4.34% from 2.88%. The firm issued $72.1M of 7.75% unsecured notes, ran ATM equity sales while authorizing a $25M repurchase, delivered a -11.92% market return for 2025, and faces a material risk of another distribution cut.

Analysis

Oxford Square’s problem is a classic mismatch: a convex, residual income engine (CLO equity) that amplifies mark-to-market moves sitting alongside floating-rate private loans and fixed-cost unsecured funding. The CLO equity payout is path-dependent — small spread compression or reallocation of payments in a stress scenario removes distributable cash far faster than loan coupons decline — which turns headline yield into a volatile residual claim rather than stable operational income. This makes NAV the true balance-sheet metric, not the cash distribution, because distributions can (and here have) outpace net investment income for extended stretches.

Second-order dynamics make this worse: management tools that look like liquidity management (ATMs, repurchases) can create adverse signaling and force tactical selling when valuations are weak, amplifying downside in the equity; issuing fixed-rate notes while asset yields fall creates persistent negative carry and increases refinancing risk at the next maturity wall. Competition effects matter — BDCs with cleaner balance sheets and low CLO-equity exposure will steal yield-seeking capital, compressing OXSQH’s relative multiple and increasing the cost of any future equity raise.

Near-term catalysts are predictable: an earnings quarter or asset-class specific loan stress point (e.g., software private credit) will likely prompt another distribution adjustment within months unless CLO residuals rebound sharply. A reversal is possible only if loan spreads widen enough to lift residual cashflows without triggering realized losses — a narrow window; the more probable paths are funding-cost pressure and further NAV compression over the next 3–12 months absent a marked recovery in CLO cashflows.

Key Decisions for Investors

• Short OXSQH equity (size 1–2% portfolio) with a 3–6 month horizon; target 30–40% downside if another distribution cut or NAV mark occurs. Use a 20% stop to limit gamma risk; alternatively implement a 3–6 month put spread (buy 1x ATM put, sell 1x lower-strike put) to cap premium spent while keeping payoff skew.
• Relative-value pair: short OXSQH / long MAIN (or another low-CLO BDC) sized dollar-neutral for 3–12 months. Expect 15–25% relative underperformance as capital rotates away from CLO-exposed names; maintain 25% stop on the pair if MAIN materially underperforms the sector.
• Hedge box: buy 3–9 month OXSQH OTM puts sized to cover dividend revision risk (cost <3% portfolio to insure payout volatility). This is tactical insurance against a headline distribution cut that will re-rate the common stock.
• Long senior-leveraged-loan exposure (BKLN or similar) over 6–12 months instead of CLO-equity vehicles to capture floating coupon upside without residual-tranche convexity. Expected carry over the period should outcompete CLO-equity returns on a risk-adjusted basis if CLO spreads remain compressed.